Profile data is unavailable for this security.
About the company
Principal Technologies Inc. is a Canada-based healthcare acquisition company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The Company operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
- Revenue in CAD (TTM)262.84k
- Net income in CAD-4.32m
- Incorporated2018
- Employees--
- LocationPrincipal Technologies Inc2500 - 700 West Georgia StreetVancouver V7Y 1B3CanadaCAN
- Phone+1 (604) 609-6112
- Fax+1 (604) 609-6145
- Websitehttps://www.principal-technologies.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurothera Labs Inc | 0.00 | -209.09k | 15.71m | -- | -- | 3.76 | -- | -- | -0.0116 | -0.0116 | 0.00 | 0.0493 | 0.00 | -- | -- | -- | -19.28 | -- | -21.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -143.95 | -- | -- | -- |
| Sirona Biochem Corp | -16.37k | -2.67m | 15.82m | -- | -- | -- | -- | -- | -0.0105 | -0.0105 | -0.00006 | -0.0134 | -0.0171 | -- | 1.61 | -- | -278.90 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -5.73 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| Numinus Wellness Inc | 5.33m | -10.67m | 16.32m | 35.00 | -- | -- | -- | 3.06 | -0.0366 | -0.0481 | 0.0175 | -0.0049 | 0.5827 | -- | 3.41 | -- | -116.67 | -77.90 | -231.32 | -88.05 | 44.96 | 31.24 | -200.23 | -325.94 | -- | -- | 3.02 | -- | -82.02 | -- | 51.75 | -- | -- | -- |
| Hemostemix Inc | 0.00 | -3.40m | 16.60m | -- | -- | -- | -- | -- | -0.03 | -0.03 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -453.77 | -579.31 | -- | -- | -- | -- | -- | -- | -- | -6.01 | -- | -- | -- | -- | -4.57 | -- | -- | -- |
| Avicanna Inc | 25.50m | -1.88m | 21.23m | 38.00 | -- | 6.82 | -- | 0.8326 | -0.0165 | -0.0165 | 0.2262 | 0.0264 | 1.22 | 2.89 | 10.84 | -- | -9.02 | -61.54 | -51.98 | -226.72 | 51.95 | 49.33 | -7.37 | -150.05 | 0.3804 | -- | 0.00 | -- | 51.62 | 172.88 | 58.62 | -- | -44.27 | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -6.82m | 29.03m | -- | -- | 13.48 | -- | -- | -0.1439 | -0.1439 | 0.00 | 0.0415 | 0.00 | -- | -- | -- | -173.15 | -- | -216.52 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.87 | -- | -- | -- |
| Principal Technologies Inc | 262.84k | -4.32m | 29.19m | -- | -- | -- | -- | 111.07 | -0.1043 | -0.1072 | 0.0063 | -0.0126 | 0.2272 | -- | 1.68 | -- | -372.16 | -- | -2,615.25 | -- | -- | -- | -1,637.81 | -- | -- | -223.78 | -- | -- | -44.22 | -- | -162.24 | -- | -- | -- |
| Resverlogix Corp | 0.00 | -9.61m | 30.18m | 18.00 | -- | -- | -- | -- | -0.0339 | -0.0339 | 0.00 | -0.4198 | 0.00 | -- | -- | 0.00 | -91.25 | -- | -- | -- | -- | -- | -- | -- | 0.0248 | -1.30 | -- | -- | -- | -- | 54.39 | -- | -- | -- |
| Microbix Biosystems Inc | 18.59m | -2.25m | 31.87m | 69.00 | -- | 1.15 | -- | 1.71 | -0.0161 | -0.0161 | 0.1344 | 0.1992 | 0.4923 | 1.12 | 6.44 | -- | -5.95 | 3.86 | -6.48 | 4.37 | 53.02 | 55.92 | -12.08 | 6.37 | 5.17 | -2.23 | 0.196 | -- | -26.81 | 12.04 | -163.80 | -- | -0.4115 | -- |
| MustGrow Biologics Corp | 7.54m | -6.37m | 40.23m | 0.00 | -- | 12.95 | -- | 5.34 | -0.1206 | -0.1206 | 0.1435 | 0.0494 | 1.45 | 5.49 | 45.16 | -- | -122.84 | -54.87 | -193.93 | -66.95 | 14.51 | -- | -84.52 | -341.26 | 1.25 | -103.31 | 0.1671 | -- | -91.55 | -- | -622.18 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -38.90m | 41.61m | 22.00 | -- | 0.7996 | -- | -- | -72.20 | -72.20 | 0.00 | 7.18 | 0.00 | -- | -- | 0.00 | -246.96 | -63.88 | -359.42 | -70.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -449.14 | -- | -- | -- |
Data as of Feb 10 2026. Currency figures normalised to Principal Technologies Inc's reporting currency: Canadian Dollar CAD
